(1) A substance shall be added to schedule III by
the general assembly when:
(a) The substance has a potential for abuse less than the substances
included in schedules I and II;
(b) The substance has currently accepted medical use in treatment in the
United States; and
(c) The abuse of the substance may lead to moderate or low physical
dependence or high psychological dependence.
(2) Unless specifically excepted by Colorado or federal law, or Colorado or
federal regulation, or more specifically included in another schedule, the following
controlled substances are listed in schedule III:
(a) Any material, compound, mixture, or preparation containing any quantity
of the following substances having a stimulant effect on the central nervous
system, including any salts, isomers, and salts of isomers of them that are
theoretically possible within the specific chemical designation:
(I) Any compound, mixture, or preparation in dosage unit form containing any
stimulant substance included in schedule II and which was listed as an excepted
compound on August 25, 1971, pursuant to the federal Controlled Substances
Act, and any other drug of the quantative composition shown in that list for those
drugs or which is the same except for containing a lesser quantity of controlled
substances;
(II) Benzphetamine;
(III) Chlorphentermine;
(IV) Clortermine;
(V) Phendimetrazine.
(b) Any material, compound, mixture, or preparation containing any quantity
of the following substances having a depressant effect on the central nervous
system:
(I) Any compound, mixture, or preparation containing any of the following
drugs or their salts and one or more other active medicinal ingredients not included
in any schedule:
(A) Amobarbital;
(B) Secobarbital;
(C) Pentobarbital;
(II) Any of the following drugs, or their salts, in suppository dosage form,
approved by the federal food and drug administration for marketing only as a
suppository:
(A) Amobarbital;
(B) Secobarbital;
(C) Pentobarbital;
(III) Any substance containing any quantity of a derivative of barbituric acid,
or any salt of a derivative of barbituric acid;
(IV) Chlorhexadol;
(V) Lysergic acid;
(VI) Lysergic acid amide;
(VII) Methyprylon;
(VIII) Sulfondiethylmethane;
(IX) Sulfonethylmethane;
(X) Sulfonmethane;
(XI) Tiletamine and zolazepam or any of their salts (Some trade or other
names for a tiletamine-zolazepam combination product: Telazol. Some trade or
other names for tiletamine: 2-(ethylamino)-2-(2- thienyl)-cyclohexanone. Some
trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one. flupyrazapon.).
(c) Nalorphine;
(d) Any material, compound, mixture, or preparation containing any of the
following narcotic drugs, or their salts calculated as the free anhydrous base or
alkaloid, in limited quantities as follows:
(I) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
milligrams per dosage unit, with an equal or greater quantity of an isoquinoline
alkaloid of opium;
(II) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
milligrams per dosage unit, with one or more active, nonnarcotic ingredients in
recognized therapeutic amounts;
(III) Not more than 300 milligrams of hydrocodone per 100 milliliters or not
more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an
isoquinoline alkaloid of opium;
(IV) Not more than 300 milligrams of hydrocodone per 100 milliliters or not
more than 15 milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
(V) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more
than 90 milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
(VI) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not
more than 15 milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
(VII) Not more than 500 milligrams of opium per 100 milliliters or per 100
grams, or not more than 25 milligrams per dosage unit, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts;
(VIII) Not more than 50 milligrams of morphine per 100 milliliters or per 100
grams with one or more active, nonnarcotic ingredients in recognized therapeutic
amounts.
(e) Anabolic steroids.
(f) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin
capsule in a federal food and drug administration approved drug product [Other
names for dronabinol: (6aR-trans)-6a,7,8,10a- tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d] pyran-1-o1, or (-)-delta-9-(trans)-tetrahydrocannabinol];
(g) Ketamine, its salts, isomers, and salts of isomers [Other names for
ketamine: (+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone].
(3) The board may exempt by rule a compound, mixture, or preparation
containing any stimulant or depressant substance listed in paragraph (a) or (b) of
subsection (2) of this section from the application of all or part of this article if the
compound, mixture, or preparation contains one or more active medicinal
ingredients not having a stimulant or depressant effect on the central nervous
system and if the admixtures are in combinations, quantity, proportion, or
concentration that vitiate the potential for abuse of the substances having a
stimulant or depressant effect on the central nervous system.